These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8232098)

  • 41. Progression of renal failure: role of apolipoprotein B-containing lipoproteins.
    Attman PO; Samuelsson O; Alaupovic P
    Kidney Int Suppl; 1997 Dec; 63():S98-101. PubMed ID: 9407433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Lipid and lipoprotein studies in nephrotic syndrome cases in childhood].
    László A; Havass Z; Joó I; Bodrogi T; Turi S
    Kinderarztl Prax; 1985 Apr; 53(4):199-203. PubMed ID: 4010160
    [No Abstract]   [Full Text] [Related]  

  • 43. The influence of hypoalbuminemia in the generation of nephrotic hyperlipidemia.
    Joven J; Espinel E; Simó JM; Vilella E; Camps J; Oliver A
    Atherosclerosis; 1996 Oct; 126(2):243-52. PubMed ID: 8902150
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia.
    Masuda D; Nakagawa-Toyama Y; Nakatani K; Inagaki M; Tsubakio-Yamamoto K; Sandoval JC; Ohama T; Nishida M; Ishigami M; Yamashita S
    Eur J Clin Invest; 2009 Aug; 39(8):689-98. PubMed ID: 19490064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lipid abnormalities in the nephrotic syndrome: causes, consequences, and treatment.
    Wheeler DC; Bernard DB
    Am J Kidney Dis; 1994 Mar; 23(3):331-46. PubMed ID: 8128933
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hyperlipidaemia of the nephrotic syndrome--the search for a nephrotic factor.
    Joven J; Vilella E
    Nephrol Dial Transplant; 1995; 10(3):314-6. PubMed ID: 7792024
    [No Abstract]   [Full Text] [Related]  

  • 47. Anti-oxidant status in relation to lipoproteins, leptin and pro-inflammatory cytokines in children with steroid-sensitive nephrotic syndrome.
    Ece A; Atamer Y; Gürkan F; Bilici M; Koçyiğit Y
    Nephrology (Carlton); 2004 Dec; 9(6):366-73. PubMed ID: 15663638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Nephrotic syndrome: pathophysiology, classification and diagnostic criteria].
    Togawa A; Yamamoto T; Hishida A
    Nihon Rinsho; 2004 Oct; 62(10):1777-83. PubMed ID: 15500118
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postprandial lipoproteins in non-insulin-dependent diabetes mellitus.
    Coppack SW
    Diabet Med; 1997 Aug; 14 Suppl 3():S67-74. PubMed ID: 9272617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanisms and treatment of dyslipidemia of renal diseases.
    Toto RD; Vega GL; Grundy SM
    Curr Opin Nephrol Hypertens; 1993 Sep; 2(5):784-90. PubMed ID: 7922219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hyperlipidemia in nephrotic syndrome].
    Heaf JG
    Ugeskr Laeger; 1991 Aug; 153(35):2414-6. PubMed ID: 1949240
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cholesterol metabolism in glomerular cells: effect of lipoproteins from nephrotic patients.
    Wanner C; Krämer-Guth A; Nauck M; Quaschning T; Pavenstädt H; Schollmeyer P
    Miner Electrolyte Metab; 1996; 22(1-3):39-46. PubMed ID: 8676822
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of fibre in the treatment of secondary hyperlipidaemia in nephrotic patients.
    Gentile MG; Ciceri R; Manna GM; Delle Fave A; Zanoni C; Raschioni E; Combi S; Maiocchi V; D'Amico G
    Eur J Clin Nutr; 1995 Oct; 49 Suppl 3():S239-41. PubMed ID: 8549536
    [No Abstract]   [Full Text] [Related]  

  • 54. Acquired hyperlipidemia (secondary dyslipoproteinemias).
    Chait A; Brunzell JD
    Endocrinol Metab Clin North Am; 1990 Jun; 19(2):259-78. PubMed ID: 2192873
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The influence of apoprotein epsilon 2 homozygosity on nephrotic hyperlipidemia.
    Joven J; Vilella E
    Clin Nephrol; 1997 Sep; 48(3):141-5. PubMed ID: 9342484
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum lipids in nephrotic syndrome.
    Banerjee SK; Sarkar AK; Chugh KS; Bansal VK; Chhuttani PN
    J Assoc Physicians India; 1972 Sep; 20(9):651-8. PubMed ID: 4654886
    [No Abstract]   [Full Text] [Related]  

  • 57. Distribution of pathologic findings in individuals with nephrotic proteinuria according to serum albumin.
    Gupta K; Iskandar SS; Daeihagh P; Ratliff HL; Bleyer AJ
    Nephrol Dial Transplant; 2008 May; 23(5):1595-9. PubMed ID: 18065791
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lipid and lipoprotein metabolism in chronic kidney disease.
    Kaysen GA
    J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Studies on the correlation of the selectivity of proteinuria and serum lipoproteins].
    Jovanović S; Stanulović M; Miletić D; Stanković J
    Med Pregl; 1976; 29(1-2):33-7. PubMed ID: 1256366
    [No Abstract]   [Full Text] [Related]  

  • 60. Disorders of blood-lipids in renal disease.
    Cramp DG; Moorhead JF; Wills MR
    Lancet; 1975 Mar; 1(7908):672-3. PubMed ID: 47091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.